Publications by authors named "Axel Villani"

Claim this Profile
T
The Dose-Response Relationship between Tobacco Smoking and Hidradenitis Suppurativa: Results from an Observational Study of 1,689 Patients.
Marine Chastagner, Léa Donzier, Farida Benhadou, Axel P Villani, Philippe Guillem

Dermatology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a Paradigm Shift in Delivering Hidradenitis Suppurativa Care: a Narrative Review.
Falk G Bechara, Angelo V Marzano, Antonio Martorell, Hessel H van der Zee, Valeria Jordan M, Axel P Villani

Dermatol Ther (Heidelb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis Suppurativa.
Louise Gouvrion, Maia Delage, Axel P Villani, Sarah Le Naour, Charlotte Fite

JAMA Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidradenitis suppurativa: a multidisciplinary challenge!
Axel Villani

Eur J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidradenitis suppurativa: pathogenesis.
Axel Villani

Eur J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Satisfaction in Patients with Hidradenitis Suppurativa: A Real-World Survey from the EU5 and USA.
John R Ingram, Vincenzo Bettoli, Jasmine I Espy, Georgios Kokolakis, Antonio Martorell, Axel P Villani

Dermatology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial.
Alexa B Kimball, Falk G Bechara, Aysha Badat, Evangelos J Giamarellos-Bourboulis, Alice B Gottlieb, Axel P Villani

Br J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
13th European Hidradenitis Suppurativa (EHSF) e.V. Conference-Imaging Future Transitions.
Christos C Zouboulis, Philippe Guillem, Axel P Villani

Exp Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of adalimumab to overcome delayed wound healing after wide excision for hidradenitis suppurativa.
Marine Chastagner, Philippe Guillem, Denis Jullien, Marie Danset, Axel Patrice Villani

Eur J Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab.
Thierry Passeron, Jean-Luc Perrot, Denis Jullien, Catherine Goujon, Mireille Ruer, Axel P Villani

JAMA Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The patient's perspective on the burden of psoriasis: findings based on the ROCQ, an online survey.
Nathalie Quiles-Tsimaratos, Alexandre Gherardi, Anne Crochard, Mélanie Hueber, Emilie Pain, Axel P Villani

Eur J Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When a molecular signature helps to manage a case of eosinophilic dermatosis.
Inès Chircop, Victoire Reynaud, Axel P Villani, Marine Chastagner

Eur J Dermatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic Cellulitis.
Johanna Morot, Ester Del Duca, Marine Chastagner, Marie Fernandes, Yeriel Estrada, Axel P Villani

JAMA Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre study.
Muslih Alzahrani, Victor Coste, Maria Polina Konstantinou, Ziad Reguiai, Axel Villani

Clin Exp Dermatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Alexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, Ziad Reguiai, Alice B Gottlieb, Axel P Villani

Lancet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untargeted metabolomics profiling identifies onycholysis-specific signature in psoriasis.
Emmanuel F Massy, Cyrille B Confavreux, Kamara Ammari, Jessica Ramos, Christelle Roger, Axel P Villani

Joint Bone Spine· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
Morgane Condamina, Laetitia Penso, Viet-Thi Tran, Claire Hotz, Philippe Guillem, Axel Patrice Villani

Dermatology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitis.
Tali Czarnowicki, Hyun Je Kim, Axel P Villani, Jacob Glickman, Ester Del Duca

Allergy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response.
Axel P Villani, Ana B Pavel, Jianni Wu, Marie Fernandes, Catherine Maari

Allergy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distal phalangeal bone erosions observed by HR-pQCT in patients with psoriatic onycholysis.
Axel P Villani, Stéphanie Boutroy, Céline Coutisson, Marie-Christine Carlier, Loïs Barets

Rheumatology (Oxford)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massive clonal expansion of polycytotoxic skin and blood CD8 T cells in patients with toxic epidermal necrolysis.
Axel Patrice Villani, Aurore Rozieres, Benoît Bensaid, Klara Kristin Eriksson, Amandine Mosnier

Sci Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Determining Affected Sites in Hidradenitis Suppurativa.
Farida Benhadou, Axel Patrice Villani, Philippe Guillem

Dermatology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
Peter Theut Riis, Ditte Marie Saunte, Viktoria Sigsgaard, Axel Patrice Villani, Philippe Guillem

Arch Dermatol Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Le choix thérapeutique : médicaments du psoriasis et grossesse avant, pendant et après la grossesse.
Axel P Villani

Eur J Dermatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective Study.
Clémentine Carlet, Damien Bichard, Marie Aleth Richard, Emmanuel Mahé, Clémence Saillard, Axel Villani

Dermatol Res Pract· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis